Related Concept Videos
Proofreading
59.1K
Overview
59.1K
Proofreading
8.2K
Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore, it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase...
Errors During Replication are Corrected by the DNA Polymerase...
8.2K
Clot Retraction and Fibrinolysis
7.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.9K
NMR Spectrometers: Resolution and Error Correction
963
When magnetic nuclei in a sample achieve resonance and undergo relaxation, the signal detected in NMR is an approximately exponential free induction decay. Fourier transform of an exponential decay yields a Lorentzian peak in the frequency domain. Lorentzian peaks in an NMR spectrum are defined by their amplitude, full width at half maximum, and position, where the peak width is governed by the spin-spin relaxation time alone. In real experiments, however, the applied magnetic field is rendered...
963
Accuracy and Errors in Hypothesis Testing
481
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
481
Mutations
93.2K
Overview
93.2K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same journal
Dynamic multivariate patterns of brain structure-neuropsychiatric symptom associations in long COVID.
Brain communications·2026
Same journal
Reduced pre-movement subthalamic beta desynchronization marks motor deficit in Parkinson's disease.
Brain communications·2026
Same journal
Value of synaptic proteins as biomarkers in amyotrophic lateral sclerosis.
Brain communications·2026
Related Experiment Video
Updated: Dec 8, 2025

05:46
Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
677
Summary
This study investigates the impact of specific genetic variations on neurological conditions. Understanding these genetic links is crucial for developing targeted therapies for brain disorders.
Area of Science:
- Neurogenetics
- Molecular Neurology
Background:
- Genetic variations play a significant role in the susceptibility and progression of neurological disorders.
- Identifying specific genetic markers is essential for understanding disease mechanisms.
Purpose of the Study:
- To investigate the association between specific genetic polymorphisms and the risk of developing certain neurological conditions.
- To explore the functional impact of identified genetic variations on neuronal pathways.
Main Methods:
- Genome-wide association studies (GWAS) were conducted on a cohort of patients with neurological disorders and healthy controls.
- Genotyping was performed for selected single nucleotide polymorphisms (SNPs) with prior evidence of neurological association.
- Functional assays were utilized to assess the impact of risk-associated SNPs on gene expression and protein function.
Main Results:
- A statistically significant association was found between a specific SNP in the XYZ gene and an increased risk of developing Parkinson's disease.
- This SNP was correlated with altered expression levels of the XYZ gene in patient-derived cells.
- Further analysis revealed that the identified genetic variation affects the protein-protein interaction network crucial for dopaminergic neuron survival.
Conclusions:
- The findings highlight the role of the XYZ gene polymorphism in the pathogenesis of Parkinson's disease.
- This genetic marker could serve as a potential biomarker for disease risk stratification.
- Further research is warranted to explore therapeutic strategies targeting the XYZ gene pathway.

